Fermented green tea extract alleviates obesity and related complications and alters gut microbiota composition in diet-induced obese mice

Journal of Medicinal Food

Volumn 18, Issue 5, 2015, Pages 549-556

  Seo, Dae Bang ^a   Jeong, Hyun Woo ^b   Cho, Donghyun ^b   Lee, Bum Jin ^b   Lee, Ji Hae ^b   Choi, Jae Young ^b   Bae, Il Hong ^b   Lee, Sung Joon ^a  

^a Korea University   (South Korea)

^b AmorePacific Corporation   (South Korea)

Author keywords

fatty liver; green tea; health functional food; insulin resistance; obesity

Indexed keywords

ANTIOBESITY AGENT; FERMENTED GREEN TEA EXTRACT; GLUCOSE; GREEN TEA EXTRACT; LIPID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ANTIOXIDANT; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEROIDETES; CONTROLLED STUDY; DIET INDUCED OBESITY; DOWN REGULATION; ENERGY METABOLISM; FAT MASS; FATTY LIVER; FERMENTED PRODUCT; FIRMICUTES; FOOD INTAKE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HYPERLIPIDEMIA; INSULIN RESISTANCE; INTESTINE FLORA; LIPID BLOOD LEVEL; LIPID DIET; LIPID STORAGE; LIPOGENESIS; MALE; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PREVOTELLA; PRIORITY JOURNAL; UPREGULATION; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE; ADVERSE EFFECTS; ANIMAL; BACTERIUM; C57BL MOUSE; CAMELLIA SINENSIS; CHEMISTRY; CLASSIFICATION; DRUG EFFECTS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LIPID METABOLISM; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; OBESITY;

CAMELLIA SINENSIS; MUS;

ANIMALS; ANTIOXIDANTS; BACTERIA; CAMELLIA SINENSIS; DIET, HIGH-FAT; GASTROINTESTINAL MICROBIOME; HUMANS; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PLANT EXTRACTS;

EID: 84929999595     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2014.3265     Document Type: Article

References (46)

1. Kopelman PG. Obesity as a medical problem. Nature 2000; 404: 635-643
2. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-519
3. Qin J, Li Y, Cai Z, Li S, et al.: A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012; 490: 55-60
4. Sanz Y, Santacruz A, Gauffin P. Gut microbiota in obesity and metabolic disorders. Proc Nutr Soc 2010; 69: 434-441
5. Cani PD, Delzenne NM. Interplay between obesity and associated metabolic disorders: New insights into the gut microbiota. Curr Opin Pharmacol 2009; 9: 737-743
6. Wu X, Ma C, Han L, Nawaz M, et al.: Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol 2010; 61: 69-78
7. Cani PD, Bibiloni R, Knauf C, Waget A, et al.: Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57: 1470-1481
8. Le Chatelier E, Nielsen T, Qin J, Prifti E, et al.: Richness of human gut microbiome correlates with metabolic markers. Nature 2013; 500: 541-546
9. Backhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007; 104: 979-984
10. Backhed F, Ding H, Wang T, Hooper LV, et al.: The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101: 15718-15723
11. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, et al.: Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005; 102: 11070-11075
12. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, et al.: An obesity-Associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1031
13. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: Human gut microbes associated with obesity. Nature 2006; 444: 1022-1023
14. Schwiertz A, Taras D, Schafer K, Beijer S, et al.: Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 2010; 18: 190-195
15. Park JA, Tirupathi Pichiah PB, Yu JJ, Oh SH, et al.: Anti-obesity effect of kimchi fermented with Weissella koreensis OK1-6 as starter in high-fat diet-induced obese C57BL/6J mice. J Appl Microbiol 2012; 113: 1507-1516
16. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, et al.: Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci 2011; 94: 3288-3294
17. Hsu TF, Kusumoto A, Abe K, Hosoda K, et al.: Polyphenolenriched oolong tea increases fecal lipid excretion. Eur J Clin Nutr 2006; 60: 1330-1336
18. Yang M, Wang C, Chen H. Green, oolong and black tea extracts modulate lipid metabolism in hyperlipidemia rats fed highsucrose diet. J Nutr Biochem 2001; 12: 14-20
19. Lee JE, Lee BJ, Chung JO, Shin HJ, et al.: 1H NMR-based metabolomic characterization during green tea (Camellia sinensis) fermentation. Food Res Int 2011; 44: 597-604
20. Jeong HW, Lee JW, Kim WS, Choe SS, et al.: A newly identified CG301269 improves lipid and glucose metabolism without body weight gain through activation of peroxisome proliferatoractivated receptor alpha and gamma. Diabetes 2011; 60: 496-506
21. Salmon DM, Flatt JP. Effect of dietary fat content on the incidence of obesity among ad libitum fed mice. Int J Obes 1985; 9: 443-449
22. Queipo-Ortuno MI, Seoane LM, Murri M, Pardo M, et al.: Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels. PLoS One 2013; 8: e65465
23. Dasu MR, Jialal I. Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors. Am J Physiol Endocrinol Metab 2010; 300: E145-E154
24. Tripathy D, Mohanty P, Dhindsa S, Syed T, et al.: Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 2003; 52: 2882-2887
25. Tripathy D, Aljada A, Dandona P. Free fatty acids (FFA) and endothelial dysfunction; role of increased oxidative stress and inflammation.-To: Steinberg et al. (2002) Vascular function, insulin resistance and fatty acids. Diabetologia 2003; 46: 300-301
26. Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: Defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 2002; 32 Suppl 3: 14-23
27. Sears CL. A dynamic partnership: Celebrating our gut flora. Anaerobe 2005; 11: 247-251
28. Gill SR, Pop M, Deboy RT, Eckburg PB, et al.: Metagenomic analysis of the human distal gut microbiome. Science 2006; 312: 1355-1359
29. Wu GD, Chen J, Hoffmann C, Bittinger K, et al.: Linking longterm dietary patterns with gut microbial enterotypes. Science 2011; 334: 105-108
30. Morgan K, Uyuni A, Nandgiri G, Mao L, et al.: Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2008; 20: 843-854
31. Boden G. Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. Curr Diab Rep 2006; 6: 177-181
32. Kim WS, Lee YS, Cha SH, Jeong HW, et al.: Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. Am J Physiol Endocrinol Metab 2009; 296: E812-E819
33. Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, et al.: Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med 2000; 6: 998-1003
34. Ashida H, Furuyashiki T, Nagayasu H, Bessho H, et al.: Antiobesity actions of green tea: Possible involvements in modulation of the glucose uptake system and suppression of the adipogenesisrelated transcription factors. Biofactors 2004; 22: 135-140
35. Cunha CA, Lira FS, Rosa Neto JC, Pimentel GD, et al.: Green tea extract supplementation induces the lipolytic pathway, attenuates obesity, and reduces low-grade inflammation in mice fed a high-fat diet. Mediators Inflamm 2013; 2013: 635470
36. Masterjohn C, Bruno RS. Therapeutic potential of green tea in nonalcoholic fatty liver disease. Nutr Rev 2012; 70: 41-56
37. Park HJ, Lee JY, Chung MY, Park YK, et al.: Green tea extract suppresses NF-kappa B activation and inflammatory responses in diet-induced obese rats with nonalcoholic steatohepatitis. J Nutr 2012; 142: 57-63
38. Chung MY, Park HJ, Manautou JE, Koo SI, et al.: Green tea extract protects against nonalcoholic steatohepatitis in ob/ob mice by decreasing oxidative and nitrative stress responses induced by proinflammatory enzymes. J Nutr Biochem 2012; 23: 361-367
39. Park HJ, DiNatale DA, Chung MY, Park YK, et al.: Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice. J Nutr Biochem 2011; 22: 393-400
40. Bruno RS, Dugan CE, Smyth JA, DiNatale DA, et al.: Green tea extract protects leptin-deficient, spontaneously obese mice from hepatic steatosis and injury. J Nutr 2008; 138: 323-331
41. Sae-Tan S, Rogers CJ, Lambert JD. Voluntary exercise and green tea enhance the expression of genes related to energy utilization and attenuate metabolic syndrome in high fat fed mice. Mol Nutr Food Res 2014; 58: 1156-1159
42. Lee HC, Jenner AM, Low CS, Lee YK. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res Microbiol 2006; 157: 876-884
43. Jin JS, Touyama M, Hisada T, Benno Y. Effects of green tea consumption on human fecal microbiota with special reference to Bifidobacterium species. Microbiol Immunol 2012; 56: 729-739
44. Rastmanesh R. High polyphenol, low probiotic diet for weight loss because of intestinal microbiota interaction. Chem Biol Interact 2011; 189: 1-8
45. Nakai M, Fukui Y, Asami S, Toyoda-Ono Y, et al.: Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. J Agric Food Chem 2005; 53: 4593-4598
46. Toyoda-Ono Y, Yoshimura M, Nakai M, Fukui Y, et al.: Suppression of postprandial hypertriglyceridemia in rats and mice by oolong tea polymerized polyphenols. Biosci Biotechnol Biochem 2007; 71: 971-976